A randomized, double-blind, 24‐week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder-Reference-Cited by-同舟云学术

A randomized, double-blind, 24‐week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder

Published:2005-09-20 Issue:10 Volume:21 Page:1659-1668
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Colonna Lucien¹,Andersen Henning Friis²,Reines Elin Heldbo²

Affiliation:

1. University Hospital, Rouen Cedex, France

2. H. Lundbeck A/S, Copenhagen, Denmark

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/030079905X65484

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Irritable Personality Trait and Type of Antidepressant Prescribed Moderates the Association between genotypes of HTR1A-rs6295 or HTR2A-rs6311 with Treatment Response.;2024-05-21

2. Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis;BMC Psychiatry;2023-11-24

3. Selective LC–MS/MS determination of citalopram enantiomers and application to a pharmacokinetic evaluation of generic and reference formulations;Biomedical Chromatography;2021-10-03

4. The efficacy of escitalopram in major depressive disorder: a multicenter randomized, placebo-controlled double-blind study;International Clinical Psychopharmacology;2021-05

5. Impact of gender, depression severity and type of depressive episode on efficacy and safety of escitalopram: an observational study on major depressive disorder patients in southern India;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2021-03-31